Literature DB >> 19731089

A histochemical approach to the diagnosis of visceral pleural infiltration by non-small cell lung cancer.

Arne Warth1, Thomas Muley, Esther Herpel, Joachim Pfannschmidt, Hans Hoffmann, Hendrik Dienemann, Peter Schirmacher, Philipp A Schnabel.   

Abstract

INTRODUCTION: Although invasion of the visceral pleura (VPI) by non-small cell lung cancer (NSCLC) is a TNM-relevant diagnostic criterion and is known to affect the patients' prognoses, until recently there were no standardized or internationally accepted guidelines. This resulted in a diagnostic ambiguity leading to different tumor staging systems and to hardly comparable patient collectives in research studies world wide. The major problem in this issue is to exactly define what constitutes for the diagnosis of VPI with respect to anatomical landmarks.
METHODS: In order to address this problem we investigated the pleural infiltration depth of 173 NSCLC specimens without lymph node metastases and proven tumor-related death using elastic stains and a scoring system referring to prominent pleural elastic layers, the lamina elastica externa and interna, as anatomical landmarks.
RESULTS: Performing comparative Kaplan-Meier survival analyses for each patient collective we could not find any significant difference in the patients' survival. This indicates that a differential evaluation of the tumor infiltration depth according to the elastic layers is not practicable.
CONCLUSIONS: Our findings support the consequent application of the recently proposed, pragmatic approach of the international staging committee for lung cancer (IASLC) to define an internationally accepted and standardized staging system for VPI.

Entities:  

Mesh:

Year:  2010        PMID: 19731089     DOI: 10.1007/s12253-009-9201-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  15 in total

1.  NHLBI workshop summaries. Pleural cell biology in health and disease.

Authors:  V B Antony; S A Sahn; B Mossman; D B Gail; A Kalica
Journal:  Am Rev Respir Dis       Date:  1992-05

2.  Visceral pleural invasion in lung cancer: recognizing histologic parameters that impact staging and prognosis.

Authors:  Kelly J Butnor; Kumarasen Cooper
Journal:  Adv Anat Pathol       Date:  2005-01       Impact factor: 3.875

3.  Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.

Authors:  Kimihiro Shimizu; Junji Yoshida; Kanji Nagai; Mitsuyo Nishimura; Genichiro Ishii; Yasuo Morishita; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2005-07       Impact factor: 5.209

4.  Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.

Authors:  D Manac'h; M Riquet; J Medioni; F Le Pimpec-Barthes; A Dujon; C Danel
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

Review 5.  The significance of pleural elastica invasion by lung carcinomas.

Authors:  B Gallagher; S J Urbanski
Journal:  Hum Pathol       Date:  1990-05       Impact factor: 3.466

6.  Interobserver agreement on what constitutes visceral pleural invasion by non-small cell lung carcinoma: an internet-based assessment of international current practices.

Authors:  Kelly J Butnor; Robin T Vollmer; Hagen Blaszyk; Katharina Glatz
Journal:  Am J Clin Pathol       Date:  2007-10       Impact factor: 2.493

7.  Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance.

Authors:  Toshihiro Osaki; Akira Nagashima; Takashi Yoshimatsu; Sosuke Yamada; Kosei Yasumoto
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

8.  Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.

Authors:  Y Ichinose; N Hara; M Ohta; T Yano; K Maeda; H Asoh; Y Katsuda
Journal:  J Thorac Cardiovasc Surg       Date:  1993-07       Impact factor: 5.209

9.  Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.

Authors:  Kimihiro Shimizu; Junji Yoshida; Kanji Nagai; Mitsuyo Nishimura; Tomoyuki Yokose; Genichiro Ishii; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

10.  Prognostic significance of visceral pleural invasion in the forthcoming (seventh) edition of TNM classification for lung cancer.

Authors:  Hyo Sup Shim; In Kyu Park; Chang Young Lee; Kyung Young Chung
Journal:  Lung Cancer       Date:  2009-01-06       Impact factor: 5.705

View more
  5 in total

Review 1.  [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].

Authors:  A Warth
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

2.  Invasion of the inner and outer layers of the visceral pleura in pT1 size lung adenocarcinoma measuring ≤ 3 cm: correlation with malignant aggressiveness and prognosis.

Authors:  Makoto Hamasaki; Fumiaki Kato; Kaori Koga; Hiroyuki Hayashi; Mikiko Aoki; Yoshihiro Miyake; Akinori Iwasaki; Kazuki Nabeshima
Journal:  Virchows Arch       Date:  2012-09-22       Impact factor: 4.064

3.  DRAQ5 and Eosin ('D&E') as an Analog to Hematoxylin and Eosin for Rapid Fluorescence Histology of Fresh Tissues.

Authors:  Katherine N Elfer; Andrew B Sholl; Mei Wang; David B Tulman; Sree H Mandava; Benjamin R Lee; J Quincy Brown
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

4.  Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer.

Authors:  Yangki Seok; Ji Yun Jeong; Eungbae Lee
Journal:  Thorac Cancer       Date:  2017-02-21       Impact factor: 3.500

5.  The combination of computed tomography features and circulating tumor cells increases the surgical prediction of visceral pleural invasion in clinical T1N0M0 lung adenocarcinoma.

Authors:  Jinghan Shi; Fei Li; Fujun Yang; Zhengwei Dong; Yan Jiang; Dania Nachira; Justyna Chalubinska-Fendler; Terence T Sio; Yo Kawaguchi; Hiromitsu Takizawa; Xiao Song; Yang Hu; Liang Duan
Journal:  Transl Lung Cancer Res       Date:  2021-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.